JIR
PAHC icon

James Investment Research’s Phibro Animal Health PAHC Stock Holding History

James Investment Research’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,260
Closed -$346K – 379
2026
Q1 		$346K Hold
6,260
– – 0.04% 285
2025
Q4 		$234K Buy
+6,260
New +$254K 0.03% 326

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

James Investment Research's PAHC Position: Q2 2026 in Review

James Investment Research sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 6,260 shares — an estimated $346K sold.

James Investment Research first reported a position in PAHC in Q4 2025 and held it in 2 quarters. The position peaked at $346K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • James Investment Research reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • James Investment Research sold 6,260 Phibro Animal Health shares in Q2 2026, an estimated $346K.
  • James Investment Research first reported a position in Phibro Animal Health in Q4 2025 and held it in 2 quarters.
  • James Investment Research's Phibro Animal Health position peaked at $346K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on James Investment Research's 13F filing for Q2 2026, filed 24 Jul 2026.